Last edition
News about "Myriad Genetics"
Zydus Lifesciences Inks Exclusive Deal with Myriad Genetics for Cancer Risk Tests in India
Zydus Lifesciences has entered into an exclusive agreement with US-based Myriad Genetics to introduce clinically validated cancer-risk assessment diagnostic tests in India, aimed at enabling personalised, evidence-based cancer care and strengthening early detection and preventive oncology efforts in the country.
Myriad Genetics | 19/12/2025 | By News Bureau | 143
ANGLE Forms Strategic Collaboration with Myriad Genetics
ANGLE plc has entered into a collaboration with Myriad Genetics to evaluate circulating tumour cell DNA using ANGLE’s Parsortix system alongside Myriad’s tissue-based assays, aiming to advance precision oncology.
Myriad Genetics | 22/08/2025 | By Mrinmoy Dey | 142
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy